Bio-Rad Introduces New Pro-Human Diabetes Assay Panel
18 Jun 2008Product news
Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced new Bio-Plex Pro™ Human Diabetes Assay Panels for Bio-Rad’s Bio-Plex® suspension array system.
Offered as one multiplex and two singleplex assays designed to achieve optimal working assay ranges, the new pro-human diabetes assay delivers accurate and reproducible multiplex measurements of human diabetes and obesity markers.
Product Features
- The pro-human assay panel consists of a premixed 12-plex of analytes (C-Peptide, ghrelin, GIP, GLP-1, glucagon, IL6, insulin, leptin, PAi-1, resistin, TNF-a, and visfatin) that work with magnetic beads, pre-blended detection antibodies, standards and controls. The singleplex assays (adiponectin and adipsin) may be mixed together to form a 2-plex assay.
- The reagent kit includes an assay buffer, wash buffer, streptavidin-PE, 96-well filter plate, sealing tape, and panel specific instructions required to prepare assays and acquire data.
- The diluents kit enables the researcher to choose the appropriate diluents kit for diluting samples, standards and controls.
All three Bio-Plex pro-human diabetes assays were validated using real patient samples.
Links
Tags
ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.